Search With Term
Recent Industry Update
- Philips acquired US-based remote medical technology company, BioTelemetry
- Deal Insignt: Antibe licensed otenaproxesul to Nuance Pharma
- Insight on why Jazz Pharmaceuticals to acquire GW Pharma?
- ViiV Healthcare’s Rukobia received EMA marketing authorisation
- Sanofi received additional indication approval for Plavix
- CoronaVac received conditional marketing authorization from NMPA China
- What is the meaning of pharmaceutical profiling?
- What is phase zero study? What it’s significance?
- Sanofi-kymab-deal: Sanofi’s acquisition of a clinical-stage biopharmaceutical company Kymab
- Covishield received emergency use authorization in India
- Glenmark introducing Remogliflozin + Vildagliptin combination first time in India
- Myovant and Pfizer’s $4.2 Billion Deal for Orgovyx
- Insight on Aurobindo and COVAXX exclusive licensing agreement
- Pfizer, BioNTech covid vaccine approval tilldate
- Chugai received MHLW, Japan marketing authorization for humanized anti-PD-L1 monoclonal antibody, Tecentriq to treat unresectable advanced/recurrent NSCLC
- Lynparza received marketing authorization by MHLW, Japan to treat advanced ovarian, prostate and pancreatic cancers
- AstraZeneca – Alexion $39 billion deal
- UK approves Pfizer-BioNTech’s COVID-19 vaccine. Rollout in week time
- Saudi Arabia signs non-binding vaccine agreement with CureVac
- Telix Pharma to acquire TheraPharm GmbH
- Case Study: Clinical basis of MHLW approval of Astellas’s Evrenzo to treat anemia of CKD in adult patients not on dialysis
- Covid 19 Vaccine development and commercialization status | More than 50 vaccine candidate under development
- PostEra codevelopment deal with NeuroLucent for Alzheimer’s disease
- AbbVie, Eisai received new indication approval for Humira to treat pyoderma gangrenosum
- Pfizer submitted application for emergency use of Covid vaccine
- Take Self Competency Test in Esxport Documentation
- Insight on VFMCRP, Fresenius Kabi distribution agreement for Veltassa to treat hyperkalemia in China
- US FDA grants priority review status to Sanofi’s BLA for avalglucosidase alfa to treat Pompe disease
- Case Study on Gliead’s Blockbuster Veklury – Sales and Strategic Planning
- Sanofi and Merck to conduct phase 2 trial of THOR-707 in combo with Keytruda
Monthly Archieves
- February 2021 (6)
- January 2021 (4)
- December 2020 (10)
- November 2020 (8)
- October 2020 (9)
- September 2020 (10)
- August 2020 (7)
- July 2020 (7)
- June 2020 (4)
- May 2020 (8)
- April 2020 (10)
- March 2020 (16)
- February 2020 (12)
- January 2020 (9)
- December 2019 (10)
- November 2019 (10)
- October 2019 (14)
- September 2019 (21)
- August 2019 (7)
- July 2019 (14)
- June 2019 (15)
- May 2019 (18)
- April 2019 (13)
- March 2019 (16)
- February 2019 (14)
- January 2019 (12)
- December 2018 (10)
- November 2018 (19)
- October 2018 (7)
- September 2018 (4)
- August 2018 (14)
- July 2018 (34)
- June 2018 (2)
- May 2018 (14)
- April 2018 (8)
- March 2018 (7)
- February 2018 (6)
- January 2018 (6)
- December 2017 (9)
- November 2017 (9)
- October 2017 (14)
- September 2017 (12)
- August 2017 (12)
- July 2017 (11)
- June 2017 (12)
- May 2017 (18)
- April 2017 (11)
- March 2017 (20)
- February 2017 (15)
- January 2017 (12)
- December 2016 (23)
- November 2016 (20)
- October 2016 (7)
- September 2016 (15)
- August 2016 (21)
- July 2016 (36)
- June 2016 (20)
- May 2016 (24)
- April 2016 (21)
- March 2016 (27)
- February 2016 (24)
- January 2016 (19)
- December 2015 (8)
- November 2015 (16)
- October 2015 (25)
- September 2015 (22)
- August 2015 (12)
- July 2015 (32)
- June 2015 (33)
- May 2015 (32)
- April 2015 (19)
- March 2015 (10)
- February 2015 (17)
- January 2015 (33)
- December 2014 (41)
- November 2014 (20)
- October 2014 (10)
- September 2014 (10)